Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 12-week, randomized, double-blind, placebo-controlled, parallel-group. fixed-dosage study to evaluate the efficacy and safety of armodafinil (50, 150, and 250 mg/day) as treatment for patients with excessive sleepiness associated with mild or moderate closed traumatic brain injury https://www.kusajili.fr:443/Trial/axrgf167aUK9UQBSoOnJ5w%24a-12-week-randomized-double-blind-placebo-controlled-parallel-group-fixed-dosage-study-to-evaluate-the-efficacy-and-safety-of-a
I have read and accept the terms of use of the site and the Privacy Policy
Send your message